Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Antigen epitope peptide of novel coronavirus T cells and application of the antigen epitope peptide

An antigenic epitope and coronavirus technology, applied in the direction of virus antigen components, viral peptides, viruses, etc., can solve the problem of no research reports on the new coronavirus

Active Publication Date: 2021-06-01
JINAN UNIVERSITY
View PDF6 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no relevant research report in the field of new coronavirus

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antigen epitope peptide of novel coronavirus T cells and application of the antigen epitope peptide
  • Antigen epitope peptide of novel coronavirus T cells and application of the antigen epitope peptide
  • Antigen epitope peptide of novel coronavirus T cells and application of the antigen epitope peptide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0058] Example 1 Prediction of New Coronavirus HLA-A2 Restricted Epitopes

[0059] 1. Experimental method

[0060] Using the MHC-I binding tool (http: / / tools.iedb.org / mhci), the SARS-CoV-2 Wuhan strain (NC_045512.2), SARS-CoV-GD01 strain (AY278489.2), MERS-CoV strain (KF600612.1) and human coronavirus OC43 strain (KF530099.1) spike (S), membrane (M) and nucleocapsid (N) protein sequences for T cell epitope prediction. The prediction method used was 2.22 (NetMHCpan-EL) recommended by IEDB, and the MHC allele selection was HLA-A*02:01 and HLA-A*02:06 (the most common HLA class I genotypes in the Chinese population) . Variant sequences for each epitope were extracted from the GISAID database (GISAID.org website) for further analysis.

[0061] 2. Experimental results

[0062] A large number of high-efficiency and specific T cell antigen epitope candidates were screened. Its information is shown in Table 1.

[0063] Table 1 Novel coronavirus T cell antigen epitope peptide:

...

Embodiment 2

[0066] Example 2 Does Mitomycin Intervention T2A2 Cells Affect the Combination with Antigen Peptides

[0067] 1. Experimental method

[0068] Take logarithmic growth state T2A2 cells (174x CEM.T2( CRL-1992TM)), seeded into 96-well plate, 10 per well 5 , select different concentrations of mitomycin (MC) (20μg / mL and 10μg / mL) and different action time (20min and 2h) to intervene in T2A2 respectively, set up 6 groups, respectively, group 1: T2A2 blank group, group 2 : T2A2+MC 10μg / mL 2h, group 3: T2A2+MC20μg / mL 20min, group 4: T2A2+10μM positive control peptide (influenza A M1 polypeptide GILGFVFTL), group 5: T2A2+MC 10μg / mL 2h+10μM positive Control peptide (influenza A M1 polypeptide GILGFVFTL), group 6: T2A2+MC 20 μg / mL 20 min+10 μM positive control peptide (influenza A M1 polypeptide GILGFVFTL). Each group has 3 replicate wells with a final volume of 200 μL. After incubation at 37°C for 4 hours, centrifuge and wash twice, label with FITC anti-human HLA-A2 (β2m) antibody, ...

Embodiment 3

[0071] Example 3 Mitomycin inhibits T2A2 cell proliferation

[0072] 1. Experimental method

[0073] Take T2A2 cells in the logarithmic growth state and plant them into 96-well plates, 10 per well 5 , take mitomycin (MC 20μg / mL), the action time (20min) to intervene in T2A2, set up 3 groups, respectively T2A2 blank group, label T2A2 with CFSE (5μM) (day 0), and label T2A2 with CFSE (5μM) (Day 7), each group had three replicate wells, and the final volume was 200 μL. Placed at 37°C, 5% CO 2 The cells were cultured in the incubator, centrifuged and washed twice after the corresponding time, and detected by flow cytometry. The experiment was carried out 3 times.

[0074] 2. Experimental results

[0075] After mitomycin MC intervened in T2A2, it could inhibit the cell proliferation ( figure 1 C and panel D). figure 1 C shows that CFSE labeling was successful (the fluorescence peak of the middle group shifted to the right on day 0). After the 7th day, CFSE still showed a si...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses antigen epitope peptide of novel coronavirus T cells and application of the antigen epitope peptide. The amino acid sequence of the antigen epitope peptide is shown as any one of SEQ ID NO: 1-13. A pMHC compound monopolymer is prepared from the pMHC compound, a pMHC compound polymer is further prepared, and the pMHC compound monopolymer can be used for detection of antigen-specific T cells in peripheral blood of a novel coronavirus infected convalescent patient and used for in-vitro T cell activation experiments. The novel coronavirus T cell antigen epitope peptide can be applied to immunodetection and vaccine research and development related to novel coronavirus, and is worthy of deep research and vigorous popularization.

Description

technical field [0001] The present invention relates to the field of biotechnology, in particular to a novel coronavirus T cell antigen epitope peptide and its application. Background technique [0002] The new coronavirus is the pathogen of a new type of infectious pneumonia that occurred at the end of 2019. At present, the source of the virus is still unclear. Gene sequencing shows that it is related to bat SARS-like coronavirus, severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East Respiratory Syndrome MERS-CoV is highly homologous. There is no specific drug report yet. The immune response mechanism of the human immune system to the new coronavirus, including antigen recognition, immune clearance mechanism, and immune memory protection mechanism, is not clear. [0003] According to the research on SARS and other coronaviruses with high homology of the new coronavirus, T cell immune response plays an important role in the body's antiviral defense and immu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/165C07K19/00G01N33/569A61K39/215A61P31/14
CPCC07K14/005C07K14/70539G01N33/56983A61K39/12A61P31/14C12N2770/20022C07K2319/00G01N2333/165C12N2770/20034
Inventor 陈国兵肖潺潺邓洁萍邱聪龄王鹏程罗钧洪高利娟
Owner JINAN UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com